Uploaded October 2026 | Updated November 2026, 3 hours ago
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Daniela Riveros Acosta, MD, of Albany Med Health System, spoke about myelitis, inflammation of the spinal cord, that is related to infection [00:00:31]. She explained three proposed mechanisms and how infections differ in timing, with examples such as herpes viruses, enteroviruses, West Nile virus, Lyme disease, HTLV-1 and HIV [00:02:08]. She discussed why an infection is sometimes not identified and what earlier studies have shown [00:06:20]. Dr. Riveros Acosta presented a retrospective review of 113 people from a Johns Hopkins cohort, covering the viruses and bacteria found, who was in the study, and how they were treated [00:08:25]. She closed with MRI findings and how people were doing at follow-up, including how many could manage daily life on their own [00:15:36].
Daniela Riveros Acosta, MD, is a neurologist in the Department of Neurology at Albany Medical Center, part of Albany Med Health System, and is board certified in neurology by the American Board of Psychiatry and Neurology. She earned her medical degree at Universidad de los Andes in Bogota in 2018 and completed her internship and neurology residency at the Icahn School of Medicine at Beth Israel Medical Center in New York. Her listed fellowship is in neuroimmunology and multiple sclerosis at Johns Hopkins University (2026). She speaks English and Spanish.
00:00 Introduction
00:31 Infections and the Spinal Cord
02:08 Three Proposed Mechanisms
03:19 Infections by Timing
05:51 Para- and Post-Infectious Myelitis
06:20 Why No Infection Is Sometimes Found
07:20 What Earlier Studies Showed
08:25 The Johns Hopkins Cohort
11:40 Which Infections Were Found
13:41 Who Was in the Study
15:36 MRI Findings
17:09 How People Did at Follow-Up
20:26 Thanks and Questions
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Daniela Riveros Acosta, MD, of Albany Med Health System, spoke about myelitis, inflammation of the spinal cord, that is related to infection [00:00:31]. She explained three proposed mechanisms and how infections differ in timing, with examples such as herpes viruses, enteroviruses, West Nile virus, Lyme disease, HTLV-1 and HIV [00:02:08]. She discussed why an infection is sometimes not identified and what earlier studies have shown [00:06:20]. Dr. Riveros Acosta presented a retrospective review of 113 people from a Johns Hopkins cohort, covering the viruses and bacteria found, who was in the study, and how they were treated [00:08:25]. She closed with MRI findings and how people were doing at follow-up, including how many could manage daily life on their own [00:15:36].
Daniela Riveros Acosta, MD, is a neurologist in the Department of Neurology at Albany Medical Center, part of Albany Med Health System, and is board certified in neurology by the American Board of Psychiatry and Neurology. She earned her medical degree at Universidad de los Andes in Bogota in 2018 and completed her internship and neurology residency at the Icahn School of Medicine at Beth Israel Medical Center in New York. Her listed fellowship is in neuroimmunology and multiple sclerosis at Johns Hopkins University (2026). She speaks English and Spanish.
00:00 Introduction
00:31 Infections and the Spinal Cord
02:08 Three Proposed Mechanisms
03:19 Infections by Timing
05:51 Para- and Post-Infectious Myelitis
06:20 Why No Infection Is Sometimes Found
07:20 What Earlier Studies Showed
08:25 The Johns Hopkins Cohort
11:40 Which Infections Were Found
13:41 Who Was in the Study
15:36 MRI Findings
17:09 How People Did at Follow-Up
20:26 Thanks and Questions
![2024 RNDS | Clinical Analysis of Children Presenting with ADEM with or without MOG-IgG
At the 2024 RNDS, Dr. Linda Nguyen discussed the characteristics and outcomes of children with acute disseminated encephalomyelitis (ADEM), focusing on those with and without the MOG antibody [00:00:10]. She highlighted the clinical features, including vision changes and intracranial pressure differences, as well as MRI and spinal fluid findings [00:01:18]. The study included patients from the Childrens Health in Dallas between 2017 and 2024, analyzing differences in age of onset, race, and hospitalization outcomes [00:02:58]. Dr. Nguyen emphasized the importance of early OCT testing and managing increased intracranial pressure in MOG-positive ADEM patients [00:13:46]. Concluding, she answered questions form the audience [00:16:00]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
You can view the presentation slides here:
https://files.wearesrna.org/symposia/2024_rnds/slides/2024RNDS_Nguyen.pdf
00:00 Introduction to ADEM and MOG Antibody
01:18 Study Objectives and Methodology
02:58 Patient Demographics and Initial Findings
04:15 Clinical and Paraclinical Features
07:29 MRI and Cerebral Spinal Fluid Analysis
09:00 Hospital Course and Treatments
10:42 Long-term Outcomes and Follow-up
13:46 Summary and Conclusions
16:00 Q&A Session 2024 RNDS | Clinical Analysis of Children Presenting with ADEM with or without MOG-IgG](https://i.ytimg.com/vi/O4i_x1s4o88/mqdefault.jpg)
![501. Transitioning from Pediatric to Adult Care with NMOSD
For this “ABCs of NMOSD” episode titled, “Transitioning from Pediatric to Adult Care with NMOSD,” Dr. Jonathan Galli joined Krissy Dilger of SRNA. Dr. Galli provided insights into the disorder and its presentation across age groups, emphasizing the importance of aggressive treatment [00:01:35]. He highlighted differences in treatment approaches and medication availability between pediatric and adult populations [00:05:54]. The discussion also explored the transition process, including timelines, support systems, and considerations for patients and families, aiming to ensure a smooth shift in care [00:10:45].
Dr. Galli received his medical degree from the University of Vermont College of Medicine in Burlington, VT, and completed his neurology residency at The University of Utah in Salt Lake City, UT, where he worked with Fellowship mentor, Dr. Clardy. As part of his fellowship training, he conducted research to look for biomarkers in individuals with NMOSD. The research investigated whether individuals have aquaporin¬-4 (AQP¬4) autoantibodies prior to their symptom onset of NMOSD, and also looked for other inflammatory biomarkers. He hopes the study will help us to understand how biomarkers occur over the course of the disorder, which will hopefully help identify predictors of disease development, and ultimately therapeutic targets. 501. Transitioning from Pediatric to Adult Care with NMOSD](https://i.ytimg.com/vi/O7RltAoMPh8/mqdefault.jpg)
![103. Dr. Jennifer Graves
The Community Meets Clinic podcast series introduces clinicians and healthcare personnel specializing in rare neuroimmune disorders. In this episode, Krissy Dilger of SRNA was joined by Dr. Jennifer Graves from UC San Diego Health. Dr. Graves shared her journey into neurology and neuroimmunology [00:02:14]. She discussed the multidisciplinary approach of her clinic at UC San Diego Health, emphasizing the importance of holistic care for patients with rare neuroimmune diseases [00:08:45]. Dr. Graves highlighted the significance of learning from rare disorders and her hope for future advancements in treatment and cures [00:16:32]. The conversation concluded with insights on maintaining well-being as a clinician and her faith in the collaborative efforts of the medical community [00:24:09]. You can view the medical profile of Dr. Graves here:
https://providers.ucsd.edu/details/32993/neurology
Jennifer Graves, MD, PhD, MAS is a Professor of Neurosciences and Vice Chair of Human Clinical Research at UCSD. She is Division Chief of Neuroimmunology and directs clinics at UCSD, the San Diego VA Hospital, and the Rady Children’s Hospital. She completed an MD and PhD in Biophysics at the University of Texas Southwestern. She trained in neurology at the University of Pennsylvania receiving the Arthur K. Asbury Award for Clinical Excellence. She completed two fellowships in Neuro-ophthalmology at the University of Pennsylvania and in Multiple Sclerosis and Clinical Research Methods at the University of California, San Francisco. Her current research focuses on the role of biological age on neuroinflammatory disease expression and the development of wearable sensors to instrument the physical exam for 21st century neurological vital signs. Her past work has included the study of genetic, environmental, and sex-related factors in neuroimmunological diseases and the application of visual outcome measures in these diseases. She is currently the North American Editor for the Multiple Sclerosis Journal.
00:00 Introduction and Welcome
00:59 Meet Dr. Jennifer Graves
01:35 Journey into Neuroimmunology
02:35 Clinic Overview and Services
03:31 Focus on Rare Neuroimmune Disorders
04:42 Multidisciplinary Clinic Team
06:27 Accepting New Patients
07:19 Self-Care as a Clinician
09:41 Commitment to Patients and Research
10:54 Hope for the Future
12:07 Conclusion 103. Dr. Jennifer Graves](https://i.ytimg.com/vi/OSRt19RtxsQ/mqdefault.jpg)

![2026 RNDS | Ask the Experts: Symptom Management Open Q&A
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Carlos A. Pardo, MD, moderated an open symptom management Q&A with Shuvro Roy, MD, Janet Dean, MS, RN, CRRN, CRNP, Elena Grebenciucova, MD, Clarice Sinn, DO, Philippines Cabahug, MD, and Sarah Hopkins, MD, MSPH. The panel discussed choosing home electrical stimulation devices and whether insurance covers them [00:01:07], abdominal pain and autonomic dysreflexia in adults and children [00:05:50], and why restorative sleep matters for pain, spasticity, and immune function [00:11:49]. They described how neurologists, primary care doctors, and families share information across health systems [00:16:44], and took audience questions on acute treatment choices and on myelitis and thinking skills [00:28:41]. The session ended with each panelists hopes for the next five years [00:34:51] and a question about skin conditions during treatment with monoclonal antibodies [00:38:58].
Carlos A. Pardo, MD, is a Professor of Neurology and Pathology and Director of the Johns Hopkins Myelitis and Myelopathy Center at Johns Hopkins University School of Medicine in Baltimore, Maryland. His clinical specialization is neuroimmunological and infectious disorders of the nervous system, with a focus on multiple sclerosis, transverse myelitis (TM), neurosarcoidosis, and neurological complications of autoimmune disorders.
Shuvro Roy, MD, is an Assistant Professor of Neurology at the University of Washington, specializing in neuroimmunology with a focus on multiple sclerosis and related neuroimmunologic disorders. He is Co-Director of the UW SRNA Center of Excellence for Rare Neuroimmune Disorders.
Janet M. Dean, MS, RN, CRRN, CRNP, is a retired board-certified Pediatric Nurse Practitioner and Certified Rehabilitation Registered Nurse. She worked at the Kennedy Krieger Institute in Baltimore, Maryland, and was an Assistant Professor in the Physical Medicine and Rehabilitation department at Johns Hopkins University School of Medicine. She has over thirty years of experience in pediatric rehabilitation and specialized in the prevention and treatment of the common health consequences of neuroimmunologic conditions.
Elena Grebenciucova, MD, is an Assistant Professor of Neurology (MS/Neuroimmunology) and neurological infections at Northwestern University in Chicago, Illinois, where she runs the Transverse Myelitis Center. She completed her neurology residency at the University of Chicago and a neuroimmunology fellowship at the Perelman School of Medicine of the University of Pennsylvania. She sees people with rare autoimmune conditions including MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), TM, and autoimmune encephalitis.
Clarice N. Sinn, DO, MHA, is an associate professor of physical medicine and rehabilitation at the University of Kentucky, where she is medical director and division chief of pediatric rehabilitation medicine at Kentucky Childrens Hospital.
Philippines Cabahug, MD, is a physician at the International Center for Spinal Cord Injury at the Kennedy Krieger Institute, board certified in physical medicine and rehabilitation (PM&R) and in spinal cord injury medicine. She completed a PM&R residency at Johns Hopkins Hospital and a fellowship in spinal cord injury medicine at Johns Hopkins Hospital/Kennedy Krieger Institute in 2013. She is Director of Musculoskeletal Ultrasound at Kennedy Krieger and a Faculty Clinical Instructor with the Department of Physical Medicine and Rehabilitation at the Johns Hopkins School of Medicine.
Sarah Hopkins, MD, MSPH, is a pediatric neurologist and Section Head of MS and Neuroinflammatory Disorders at the Childrens Hospital of Philadelphia, where she directs the multi-disciplinary Myelitis Clinic. She is an Assistant Professor of Clinical Neurology at the Perelman School of Medicine at the University of Pennsylvania. She also serves as a neurology consultant for the US Centers for Disease Control and Prevention for acute flaccid myelitis (AFM) surveillance.
00:00 Welcome and Panel Introductions
01:07 Choosing Electrical Stimulation Devices
05:50 Abdominal Pain and Autonomic Dysreflexia
11:49 Why Sleep Matters
16:44 Coordinating Care Across Providers
28:41 Acute Treatment Questions
32:59 Myelitis and Thinking Skills
34:51 Hopes for the Next Five Years
38:58 Final Question on Skin Conditions 2026 RNDS | Ask the Experts: Symptom Management Open Q&A](https://i.ytimg.com/vi/Omym0W_T1qA/mqdefault.jpg)


![Community Meets Clinic 301. Dr. Elizabeth Wilson
The Community Meets Clinic podcast series introduces clinicians and healthcare personnel specializing in rare neuroimmune disorders. In this episode hosted by Krissy Dilger of SRNA, we meet Dr. Elizabeth Wilson, a neurologist at Cincinnati Children’s Hospital and Director of its Multiple Sclerosis and Neuroimmunology Center, a designated Center of Excellence in Rare Neuroimmune Disorders. Dr. Wilson described her interest in individualized, longitudinal neuroimmunology care and the rapid evolution of treatments [01:47]. She highlighted her research on social determinants of health, including environmental stressors, caregiver impacts, and the roles of race and ethnicity in pediatric neuroinflammatory outcomes [05:21]. Dr. Wilson outlined how patients can self-refer or be referred, and described the center’s multidisciplinary model involving neuroimmunology, rheumatology, neuro-ophthalmology, neuropsychology, mental health, school support, social work, rehabilitation, and research resources [07:49]. She shared self-care strategies and expressed hope for faster diagnosis, earlier treatment, and biomarkers to better track disease activity and prevent attacks [13:31]. You can view Dr. Wilsons medical profile here:
https://www.cincinnatichildrens.org/bio/w/elizabeth-wilson
Elizabeth Wilson, MD is a pediatric neurologist at Cincinnati Children’s hospital with specialized training in neurology and neuroimmunology. She received a Bachelor of Science in Neurosicence from Lafayette College in Pennsylvania. She then completed medical school at Boston University, Pediatric residency at Boston Children’s Hospital/Boston Medical Center, and Pediatric neurology residency at Boston Medical Center. She went on to pursue a fellowship in Neuroimmunology at Massachusetts General Hospital/Boston Children’s Hospital. She recently became the director of the Multiple Sclerosis and Neuroimmunology Center (MS-NIC) at Cincinnati Children’s Hospital. Through her research she aims to understand how a patient’s environment, including life stressors, interacts with their body and genetics in inflammatory neurologic conditions, such as multiple sclerosis. She believes that by studying this relationship we can better manage these disorders and advocate for changes that will improve patient outcomes.
00:00 Introduction
01:47 Why Pediatric Neurology
03:27 Choosing Neuroimmunology
05:21 Research And Health Equity
07:49 Inside Cincinnati Children’s Hospital and the Multiple Sclerosis and Neuroimmunology Center
11:07 Multidisciplinary Team Support
13:31 Clinician Self Care
15:14 Considering The Clinic
17:29 Hope For The Future
18:50 Closing Community Meets Clinic 301. Dr. Elizabeth Wilson](https://i.ytimg.com/vi/PyZ1jDWFweI/mqdefault.jpg)

![Ask the Expert 1410. Understanding Optic Neuritis | Causes, Treatments, and Repair
In this SRNA “Ask the Expert” episode, GG deFiebre spoke with Dr. Michael Levy and Dr. Benjamin Greenberg about optic neuritis as inflammation of the optic nerve that causes pain with eye movement and rapid vision loss, and how it is most often linked to multiple sclerosis but can also be idiopathic or associated with MOGAD and NMOSD. They compared differences across these conditions (including age patterns, bilateral involvement, severity, exam findings, and typical recovery), outlined diagnostic workups such as MRI, antibody testing, and spinal fluid studies, and reviewed acute treatments [03:14]. The discussion also covered emerging therapies like Privosegtor for neuroprotection and efgartigimod alfa to lower IgG as a potential alternative to plasma exchange, and examined challenges in remyelination and stem-cell delivery approaches like Q-Cells while cautioning against unproven stem cell clinics [11:57].
Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program] at Children’s Medical Center.
Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago’s Rush Presbyterian-St. Luke’s Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor’s degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation’s first dedicated Transverse Myelitis Center.
Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children’s Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.
Michael Levy, MD, PhD is a recognized neurologist with over 15 years of clinical and research expertise in rare neuroimmunological disorders. He established the Neuroimmunology Clinic and Research Laboratory at Massachusetts General Hospital and is the Research Director in the Division of Neuroimmunology and Neuroinfectious Disease. Previously, Dr. Levy was on the faculty at Johns Hopkins University and was the founding Director of their Neuromyelitis Optica Clinic.
Clinically, Dr. Levy cares for patients with MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), and idiopathic transverse myelitis (TM). Dr. Levy is also the principal investigator (PI) on numerous patient studies and drug trials for new and improved treatments for these disorders. In 2022, Dr. Levy became the lead principal investigator for the two worldwide clinical trials in MOG antibody disease.
In the lab, Dr. Levy’s research focuses on the development of animal models of NMO and MOG with the goal of tolerization as a sustainable long-term treatment. Dr. Levy has more than 200 peer-reviewed research articles, reviews and editorials, and 3 patents covering NMO tolerization therapy, TM diagnostics, and stem cell regeneration approaches.
00:00 Welcome
01:02 Optic Neuritis Basics
02:27 Causes and Percentages
03:14 MS vs NMO vs MOG
06:07 Workup and Testing
07:51 Acute Attack Treatment
09:30 Recovery and Vision Measures
11:57 Privosegtor Neuroprotection
15:30 Efgartigimod vs Plasma Exchange
17:59 Repair vs Remyelination
20:15 Q-Cells and Stem Cell Delivery
22:22 Closing Ask the Expert 1410. Understanding Optic Neuritis | Causes, Treatments, and Repair](https://i.ytimg.com/vi/QnbQUY_HTwM/mqdefault.jpg)
![101. I have MOGAD. Now what?
In “I have MOGAD. Now what?” the first episode of the “ABCs of MOGAD” series, Krissy Dilger of SRNA was joined by Dr. Michael Levy. Dr. Levy explained the MOG antibody disease diagnosis, including its autoimmune nature and symptoms [00:01:12]. The discussion covered the history and evolution of the disorder, distinguishing it from other disorders like multiple sclerosis and neuromyelitis optica [00:05:24]. Dr. Levy detailed the diagnostic process, including antibody tests, MRIs, and clinical criteria [00:13:47]. The episode also explored treatment options, long-term effects, and the prognosis of the disease [00:29:30].
Michael Levy, MD, PhD is an Associate Professor of Neurology at Massachusetts General Hospital and Research Director of the Division of Neuroimmunology & Neuroinfectious Disease. He completed the MD/PhD program at Baylor College of Medicine with a focus on neuroscience. In 2009, Dr. Levy was appointed to the faculty as Assistant Professor at Johns Hopkins where he started the Neuromyelitis Optica Clinic and Research Laboratory and in 2019 he moved to the Massachusetts General Hospital and Harvard Medical School to develop the research program in neuroimmunology.
Clinically, Dr. Levy specializes in taking care of patients with rare neuroimmunological diseases including neuromyelitis optica, transverse myelitis, MOG antibody disease, acute disseminated encephalomyelitis and optic neuritis. In addition to neuroimmunology clinics, Dr. Levy has a special interest in patients with superficial siderosis of the central nervous system. Dr. Levy is the principal investigator on several clinical studies and drug trials for all of these conditions.
In the laboratory, Dr. Levy’s research focuses on the development of animal models of neuromyelitis optica and transverse myelitis with the goal of tolerization as a sustainable long-term treatment.
00:00 Introduction and Guest Introduction
01:33 Understanding MOG Antibody Disease
03:09 History and Discovery of MOG Antibody Disease
06:13 Diagnostic Process for MOG Antibody Disease
09:09 Acute and Long-Term Treatment Options
14:33 Choosing the Right Treatment
16:01 Rehabilitation and Follow-Up
18:42 Long-Term Effects and Prognosis
22:19 Conclusion and Future Discussions 101. I have MOGAD. Now what?](https://i.ytimg.com/vi/RaSku2l9oTo/mqdefault.jpg)